Advanced search×

Testosterone restores respiratory long term facilitation in old male rats by an aromatase-dependent mechanism.

J Physiol 589(Pt 2):409-21 (2011) PMID 21078587 PMCID PMC3043541

Steroidal sex hormones play an important role in the neural control of breathing. Previous studies in our laboratory have shown that gonadectomy in young male rats (3 months) eliminates a form of respiratory plasticity induced by intermittent hypoxia, known as long term facilitation (LTF). Testosterone replenishment restores LTF in gonadectomized male rats, and this is dependent on the conversion of testosterone to oestradiol by aromatase. By middle age (12 months), male rats no longer exhibit LTF of hypoglossal motor output; phrenic LTF is significantly reduced, and this persists into old age. We tested the hypothesis that LTF can be restored in old male rats by administration of testosterone. Intact Fischer 344 rats (>20 months) were implanted with Silastic tubing containing testosterone (T), T plus an aromatase inhibitor (T+ADT), or 5α-dihydrotestosterone (DHT), a form of testosterone not converted to oestradiol. One week post-surgery, LTF of hypoglossal and phrenic motor output was measured. By comparison with control rats, hypoglossal LTF was increased in testosterone-treated rats, with levels approaching that of normal young rats. LTF was not restored in T+ADT or DHT-treated rats. Aromatase levels in hypoglossal and phrenic nuclei did not change with age. As serum testosterone levels did not decline with age, local bioavailability of testosterone in old rats may be a limiting factor in the expression of this form of respiratory plasticity. Our findings suggest that testosterone supplementation could potentially be used to enhance upper airway control in the elderly.

DOI: 10.1113/jphysiol.2010.198200
Version: za2963e q8za5 q8zb1 q8zcd q8zd7 q8ze5 q8zf5 q8zg7

Similar articles you may find interesting…

  1. Hypogonadism, erectile dysfunction, and type 2 diabetes mellitus: what the clinician needs to know.

    Postgrad Med 122(6):165-75 (2010) PMID 21084793

    Testosterone levels and erectile function are known to decline as men age, leading to hypogonadism and erectile dysfunction (ED). Men with type 2 diabetes mellitus (T2DM) have a particularly high prevalence of hypogonadism and ED. This population also has an increased risk for cardiovascular disease...
  2. Testosterone therapy: treatment of metabolic disturbances in heart failure.

    J Cardiovasc Pharmacol Ther 16(1):14-23 (2011) PMID 21097668

    Heart failure (HF) is a complex progressive multisystem disease state with significant morbidity and mortality, which is not solely defined by pathology of the cardiovascular system but also is influenced by neurohormonal regulatory adjustments, peripheral cytokines, as well as hormonal and musculos...
  3. Testosterone supplementation and prostate cancer, controversies still exist.

    Acta Pol Pharm 67(5):543-6 (2010) PMID 20873424

    Late onset hypogonadism is a common condition in aging males. The population of men who can be potentially treated with testosterone supplementation is growing. Controversy that surrounds testosterone replacement therapy is due to generally undefined lower limits of normal testosterone level and hig...